Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance

John O'Reilly, Melvyn M Jones, Jill Parnham, Kate Lovibond, Michael Rudolf, Guideline Development Group, Phyo Kyaw Myint

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Over three million people in the United Kingdom are estimated to have chronic obstructive pulmonary disease (COPD), of whom more than two million remain undiagnosed, representing the so called “missing millions” alluded to in the draft national strategy for COPD.1 2 3 This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the management of stable chronic obstructive pulmonary disease in primary and secondary care,4 which update the COPD guidelines first published by NICE in 2004.5 The summary contains the most important recommendations relating to new diagnostic criteria for COPD, changes to the classification of severity of airflow obstruction, the need for multidimensional severity assessment, a new algorithm for inhaled drug treatments (figure⇓), and the value of early pulmonary rehabilitation.
Original languageEnglish
Article numberc3134
JournalBritish Medical Journal (Clinical Research Ed.)
Volume340
DOIs
Publication statusPublished - 25 Jun 2010

Fingerprint

Secondary Care
National Institutes of Health (U.S.)
Chronic Obstructive Pulmonary Disease
Primary Health Care
Rehabilitation
Guidelines
Lung
Pharmaceutical Preparations
Therapeutics

Keywords

  • bronchodilator agents
  • dyspnea
  • forced expiratory volume
  • humans
  • practice guidelines as topic
  • pulmonary disease, chronic obstructive
  • respiratory therapy
  • smoking cessation
  • vital capacity

Cite this

Management of stable chronic obstructive pulmonary disease in primary and secondary care : summary of updated NICE guidance. / O'Reilly, John; Jones, Melvyn M; Parnham, Jill; Lovibond, Kate; Rudolf, Michael; Guideline Development Group ; Myint, Phyo Kyaw.

In: British Medical Journal (Clinical Research Ed.), Vol. 340, c3134, 25.06.2010.

Research output: Contribution to journalArticle

O'Reilly, John ; Jones, Melvyn M ; Parnham, Jill ; Lovibond, Kate ; Rudolf, Michael ; Guideline Development Group ; Myint, Phyo Kyaw. / Management of stable chronic obstructive pulmonary disease in primary and secondary care : summary of updated NICE guidance. In: British Medical Journal (Clinical Research Ed.). 2010 ; Vol. 340.
@article{0bc4679639064c4984f0cf01db2b682d,
title = "Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance",
abstract = "Over three million people in the United Kingdom are estimated to have chronic obstructive pulmonary disease (COPD), of whom more than two million remain undiagnosed, representing the so called “missing millions” alluded to in the draft national strategy for COPD.1 2 3 This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the management of stable chronic obstructive pulmonary disease in primary and secondary care,4 which update the COPD guidelines first published by NICE in 2004.5 The summary contains the most important recommendations relating to new diagnostic criteria for COPD, changes to the classification of severity of airflow obstruction, the need for multidimensional severity assessment, a new algorithm for inhaled drug treatments (figure⇓), and the value of early pulmonary rehabilitation.",
keywords = "bronchodilator agents, dyspnea, forced expiratory volume, humans, practice guidelines as topic, pulmonary disease, chronic obstructive, respiratory therapy, smoking cessation, vital capacity",
author = "John O'Reilly and Jones, {Melvyn M} and Jill Parnham and Kate Lovibond and Michael Rudolf and {Guideline Development Group} and Myint, {Phyo Kyaw}",
year = "2010",
month = "6",
day = "25",
doi = "10.1136/bmj.c3134",
language = "English",
volume = "340",
journal = "British Medical Journal (Clinical Research Ed.)",
issn = "0267-0623",

}

TY - JOUR

T1 - Management of stable chronic obstructive pulmonary disease in primary and secondary care

T2 - summary of updated NICE guidance

AU - O'Reilly, John

AU - Jones, Melvyn M

AU - Parnham, Jill

AU - Lovibond, Kate

AU - Rudolf, Michael

AU - Guideline Development Group

AU - Myint, Phyo Kyaw

PY - 2010/6/25

Y1 - 2010/6/25

N2 - Over three million people in the United Kingdom are estimated to have chronic obstructive pulmonary disease (COPD), of whom more than two million remain undiagnosed, representing the so called “missing millions” alluded to in the draft national strategy for COPD.1 2 3 This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the management of stable chronic obstructive pulmonary disease in primary and secondary care,4 which update the COPD guidelines first published by NICE in 2004.5 The summary contains the most important recommendations relating to new diagnostic criteria for COPD, changes to the classification of severity of airflow obstruction, the need for multidimensional severity assessment, a new algorithm for inhaled drug treatments (figure⇓), and the value of early pulmonary rehabilitation.

AB - Over three million people in the United Kingdom are estimated to have chronic obstructive pulmonary disease (COPD), of whom more than two million remain undiagnosed, representing the so called “missing millions” alluded to in the draft national strategy for COPD.1 2 3 This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the management of stable chronic obstructive pulmonary disease in primary and secondary care,4 which update the COPD guidelines first published by NICE in 2004.5 The summary contains the most important recommendations relating to new diagnostic criteria for COPD, changes to the classification of severity of airflow obstruction, the need for multidimensional severity assessment, a new algorithm for inhaled drug treatments (figure⇓), and the value of early pulmonary rehabilitation.

KW - bronchodilator agents

KW - dyspnea

KW - forced expiratory volume

KW - humans

KW - practice guidelines as topic

KW - pulmonary disease, chronic obstructive

KW - respiratory therapy

KW - smoking cessation

KW - vital capacity

U2 - 10.1136/bmj.c3134

DO - 10.1136/bmj.c3134

M3 - Article

C2 - 20581031

VL - 340

JO - British Medical Journal (Clinical Research Ed.)

JF - British Medical Journal (Clinical Research Ed.)

SN - 0267-0623

M1 - c3134

ER -